Skip to content

Own blood product and steroid injections in frozen shoulder

Role of intra-articular Platelet-Rich Plasma and Methyl Prednisolone acetate injections in Adhesive Capsulitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009454
Enrollment
60
Registered
2017-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M255- Pain in joint Health Condition 2: null- Patients with adhesive capsulitis

Interventions

Intervention1: PRP Group: In group A (PRP Group), we will administer single intraarticular injection (4 ml) of PRP into the glenohumeral joint Frequency: Single injection 4ml PRP Route of Administra

Sponsors

All India Institute of Medical Sciences Bhubaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients attending PMR OPD, AIIMS BBSR and diagnosed as having unilateral adhesive capsulitis of either shoulder, as per criteria mentioned below, with duration of symptoms less than 6 months. Diagnosis of adhesive capsulitis would be according to the following criteria: i) The presence of shoulder pain ii) Limitation of both active and passive movements of the glenohumeral joint of >=25% in at list 2 directions (abduction, flexion, external rotation, internal rotation), as compared with the contralateral shoulder 2) If bilateral shoulders are involved and qualify for inclusion, only the dominant arm would be considered for intervention. 3) Age between 18 and 70 years

Exclusion criteria

Exclusion criteria: 1) Patients with inflammatory joint disease. 2) Patients who have previously undergone any intra-articular injection/invasive procedure/surgery in the shoulder joint. 3) Patients with structural/functional limitations in the shoulder joint from any other pre-existing musculoskeletal pathology or neurologic disorder. 4) Patients with poor cognitive status who are unable to follow exercise program

Design outcomes

Primary

MeasureTime frame
Primary outcome measure would be: 1) Visual Analogue Scale (VAS)-Patient-reported Pain intensity in the shoulder joint 2) SPDI (Shoulder pain and disability Index) 3) Shoulder ROM- measured by GoniometryTimepoint: 12 weeks

Secondary

MeasureTime frame
Secondary Outcome measure would be Patient Satisfaction Scale Timepoint: 12 weeks

Countries

India

Contacts

Public ContactDr Apurba Barman

All India Institute of Medical Sciences, Bhubaneswar

apurvaa23@gmail.com9438884211

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026